Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Intra-Cellular Therapies Inc ITCI

Healthcare Psychedelics
Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders. The Company leverages intracellular approach to develop treatments for people living with complex psychiatric and neurologic diseases. The Company’s product, CAPLYTA (lumateperone), is an oral, once daily atypical... see more

Recent & Breaking News (NDAQ:ITCI)

Intra-Cellular Therapies Presents Data on Symptom Improvement by Lumateperone on Negative Symptoms, Depression, and Social Function in Patients with Schizophrenia at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

GlobeNewswire May 31, 2018

Intra-Cellular Therapies to Present at the Jefferies 2018 Global Healthcare Conference

GlobeNewswire May 30, 2018

Intra-Cellular Therapies Announces Presentations on Lumateperone at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

GlobeNewswire May 29, 2018

New Research: Key Drivers of Growth for CSW Industrials, Cavco Industries, Intra-Cellular Therapies, Atrion, QAD, and A V Homes — Factors of Influence, Major Initiatives and Sustained Production

GlobeNewswire May 24, 2018

Intra-Cellular Therapies to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

GlobeNewswire May 9, 2018

Intra-Cellular Therapies Announces Presentations on Lumateperone at Two Upcoming Medical Conferences

GlobeNewswire May 4, 2018

Intra-Cellular Therapies Reports First Quarter 2018 Financial Results and Provides Corporate Update

GlobeNewswire May 3, 2018

Benzinga's Daily Biotech Pulse: Intra-cellular Moves On Poster Presentation, Earnings Beats From Vertex, Exact Sciences

Benzinga.com  April 27, 2018

Recent Analysis Shows Eagle Bulk Shipping, QCR, Intra-Cellular Therapies, PGT, Northeast, and Ferrellgas Partners Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire April 2, 2018

Intra-Cellular Therapies Announces Positive Pre-NDA Meeting with FDA for Lumateperone for the Treatment of Schizophrenia

GlobeNewswire March 13, 2018

Intra-Cellular Therapies to Present at the Cowen and Company 38th Annual Health Care Conference

GlobeNewswire March 8, 2018

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update

GlobeNewswire March 1, 2018

Intra-Cellular Therapies, Inc. to Host Earnings Call

Accesswire March 1, 2018

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast

GlobeNewswire February 22, 2018

UPDATE - Intra-Cellular Therapies to Present at RBC Capital Markets 2018 Global Healthcare Conference

GlobeNewswire February 15, 2018

Intra-Cellular Therapies to Present at Upcoming Investor Conferences

GlobeNewswire February 7, 2018

Research Report Identifies Shutterstock, Intra-Cellular Therapies, ConforMIS, Jack Henry & Associates, Instructure, and WEX with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

GlobeNewswire January 30, 2018

Newman Ferrara LLP Announces Corporate Governance Investigation of Intra-Cellular Therapies, Inc. - ITCI

Business Wire January 10, 2018

Intra-Cellular Therapies to Present at the 36th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 2, 2018

Pre-Market Technical Scan on Biotech Equities -- Spectrum Pharma, Jazz Pharma, Intra-Cellular Therapies, and Dermira

PR Newswire December 13, 2017